Live from the NIH registry
Studies recruiting near Springfield right now
Top 25 of 315 recruiting studies, sorted by proximity — each links to its official registry page
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Acute Leukemia, Newly Diagnosed
N/A
Observational 1,365 participants sought
Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Mercy Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Spinal Disease, Degenerative Disc Disease
N/A
Observational 120 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Collagen Matrix
A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia
Hemiplegia, Cerebral Palsy
N/A
Interventional 30 participants sought
Physical Therapy Program, Department of Kinesiology, University of Connecticut — Storrs, Connecticut (25.9 mi)
· Sponsor: University of Connecticut
CLOZAPINE Response in Biotype-1
Schizophrenia, Schizoaffective Disorder
Phase 4
Interventional 524 participants sought
Hartford Healthcare — Hartford, Connecticut (25.4 mi)
· Sponsor: University of Texas Southwestern Medical Center
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Pneumonia
N/A
Observational 12,500 participants sought
Starling Physicians — Hartford, Connecticut (25.4 mi)
· Sponsor: Pfizer
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Agitation
Phase 2
Interventional 150 participants sought
Elixia MA, LLC — Springfield, Massachusetts (2.8 mi)
· Sponsor: Teikoku Pharma USA, Inc.
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Phase 2
Interventional 98 participants sought
Connecticut Children's Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Giselle Sholler
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Hoffmann-La Roche
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: Janssen Research & Development, LLC
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Charcot Marie Tooth Disease
N/A
Observational 5,000 participants sought
University of Connecticut/Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: Michael Shy
Multifidus Cervicis Plane Block Vs. Sham Block For Posterior Cervical Spine Fusion Surgery
Cervical Spine Fusion
Phase 4
Interventional 38 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Hartford Hospital
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (25.4 mi)
· Sponsor: National Cancer Institute (NCI)
Burning Mouth Syndrome: Symptoms and Management
Burning Mouth Syndrome
EARLY/Phase 1
Interventional 50 participants sought
UMass Amherst — Amherst, Massachusetts (17.4 mi)
· Sponsor: University of Massachusetts, Amherst
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Schizophrenia, Bipolar I Disorder
Phase 3
Interventional 220 participants sought
Alkermes Investigator Site — Hartford, Connecticut (25.4 mi)
· Sponsor: Alkermes, Inc.
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: Children's Oncology Group
A Study to Assess Growth in Children With Idiopathic Short Stature
Idiopathic Short Stature
N/A
Observational 300 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: BioMarin Pharmaceutical
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Healthy Adult Participants
N/A
Observational 15 participants sought
Decentralized / At-Home Participation (U.S.) — Hartford, Connecticut (25.4 mi)
· Sponsor: Ecotera Health LLC
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Neuroblastoma
Phase 2
Interventional 500 participants sought
Connecticut Children's Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Giselle Sholler
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Hartford, Connecticut (25.4 mi)
· Sponsor: TG Therapeutics, Inc.
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Hartford, Connecticut (25.4 mi)
· Sponsor: Medtronic
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Medtronic Cardiovascular